IRT for DCTs

IRT for DCTs

Decentralized clinical trials enable patients to enroll and participate in clinical trials without traveling (or reducing travel) to a central investigator site.

COVID-19 caused a significant disruption in clinical development and a strain on the entire health care system, factors that helped to accelerate industry’s adoption of the decentralized strategy. Technologies to enroll and monitor patients, collect patient data remotely, and manage clinical supplies can reduce the complexities of designing and executing these patient-centric strategies.

YPrime’s IRT solutions for Decentralized Clinical Trials

  • Flexible design can accommodate early phase studies through late-stage trials with complex protocol requirements
  • Platform supports remote, hybrid, and onsite visit schedules for individual patients
  • Patient workflow feature accommodates unique visit structures and dispensation needs
  • Multiple direct-to-patient clinical supply shipping models within a single study
  • Treatment return module allows treatment to be returned by the patient, or marked lost, for drug accountability
  • Discrepancy management feature enables verification of returns without a CRA
  • Standard site IP return-to-depot module enables any kit previously reconciled to be returned to the depot
  • Reconciliation reporting feature makes it easy to monitor compliance on a site level
  • Lifecycle accountability feature provides a clear history of when materials are moved from one status to another—allocated to the patient, returned to the site (or pharmacy or depot), ready for reconciliation, reconciled
  • 24x7x365 global technical support for sites and patients

Decipher the complexities of patient randomization and clinical supply management

See How YPrime’s IRT Solutions Help You Simplify, Standardize, and Transform Your Processes.